An increase in S-glutathionylated proteins in the Alzheimer's disease inferior parietal lobule, a proteomics approach

✍ Scribed by Shelley F. Newman; Rukhsana Sultana; Marzia Perluigi; Rafella Coccia; Jian Cai; William M. Pierce; Jon B. Klein; Delano M. Turner; D. Allan Butterfield

• Publisher: John Wiley and Sons
• Year: 2007
• Tongue: English
• Weight: 192 KB
• Volume: 85
• Category: Article
• ISSN: 0360-4012
• DOI: 10.1002/jnr.21275

✦ Synopsis

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by neurofibrillary tangles, senile plaques, and loss of synapses. Many studies support the notion that oxidative stress plays an important role in AD pathogenesis. Previous studies from our laboratory employed redox proteomics to identify oxidatively modified proteins in the AD inferior parietal lobule (IPL) and hippocampus. The proteins were consistent with biochemical or pathological alterations in AD and have been central to further investigations of the disease. The present study focused on the identification of specific targets of protein S‐glutathionylation in AD and control IPL by using a redox proteomics approach. For AD IPL, we identified deoxyhemoglobin, α‐crystallin B, glyceraldehyde phosphate dehydrogenase (GAPDH), and α‐enolase as significantly S‐glutathionylated relative to these brain proteins in control IPL. GAPDH and α‐enolase were also shown to have reduced activity in the AD IPL. This study demonstrates that specific proteins are sensitive to S‐glutathionylation, which most likely is due to their sensitivity to cysteine oxidation initiated by the increase in oxidative stress in the AD brain. © 2007 Wiley‐Liss, Inc.